CD74 and lung carcinoma: Notably, blocking the MIF–CD74 interaction has been shown to reprogram macrophages toward the pro-inflammatory “M1” state and enhance anti-tumor immune responses, for example by synergistically promoting microglia M1 polarization in lung cancer models (34).